소아용 혈관 접근 시장 : 유형별, 용도별, 최종사용자별 - 세계 예측(-2030년)

The global pediatric vascular access market is projected to reach USD 833.1 million by 2030 from USD 543.0 million in 2024, at a CAGR of 7.4% during the forecast period. The pediatric vascular access market is witnessing consistent growth due to various factors such as preterm births, advancement in catheter materials in terms of safety and comfort, and growing NICU admissions.

There has also been a shift towards smart vascular access devices, particularly in North America, Europe, and the Asia Pacific, where there is an increase in hospitalizations. Overall, increased healthcare expenditure in developing markets is bringing new opportunities to market growth.

The Peripheral Intravenous Catheters (PIVC) segment of the pediatric vascular access market, by the type of catheters, is expected to hold the highest CAGR during the forecast period.

The Peripheral Intravenous Catheters (PIVC) segment within the Pediatric Vascular Access market is anticipated to exhibit the highest CAGR during the forecast period due to its critical role in facilitating safe and efficient vascular access for high-risk newborns. PIVCs are designed for short-term use, typically lasting 24-96 hours. They are preferred for administering medications, fluids, and blood products in neonatal intensive care units (NICUs), where frequent interventions are required.

The Ambulatory Surgical Centers (ASCs) segment of the pediatric vascular access market, by end user, is expected to show the second-highest growth.

ASCs are increasingly becoming a preferred alternative to traditional hospital settings for certain neonatal interventions due to their cost-effectiveness, convenience, and focus on patient-centered care. ASCs often specialize in procedures that require advanced vascular access devices, such as peripheral intravenous catheters (PIVCs), peripherally inserted central catheters (PICCs), and midline catheters. These devices are essential for managing conditions such as congenital anomalies, preterm complications, or post-surgical recovery in a controlled, less intensive setting. The ability to perform these procedures outside of a full-scale hospital environment reduces costs while maintaining high standards of care, making ASCs an attractive option for providers and patients.

Asia Pacific is expected to grow at the highest CAGR during the forecast period in the pediatric vascular access market.

The pediatric vascular access market in the Asia Pacific region is growing rapidly due to demographic, economic, and healthcare infrastructure dynamics. With a rapidly growing population and rising incidence of preterm births, particularly in China and India, the demand for specialized vascular devices tailored to neonates is surging. Governments across the region are prioritizing improvements in neonatal care, investing in advanced NICUs, and upgrading healthcare facilities to align with global standards. For instance, China's National Health Commission has launched initiatives to enhance access to critical neonatal interventions, including vascular access technologies. Japan's sophisticated healthcare ecosystem continues to adopt cutting-edge technologies such as AI-integrated monitoring systems and ultra-miniaturized catheters. Economic expansion in the Asia Pacific is further fueling market growth as rising disposable incomes and expanding middle-class populations increase access to premium medical solutions. South Korea and Singapore are witnessing heightened adoption of smart vascular devices, driven by a culture of technological integration in healthcare.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1: 28%, Tier 2: 34%, and Tier 3: 38%
• By Designation: C-level: 40%, Director Level: 26%, and Others: 34%
• By Region: North America: 25%, Europe: 41%, Asia Pacific: 30%, Latin America: 3%, and Middle East & Africa: 1%

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.0 billion, Tier 2 = USD 1.0 billion to USD 10.0 billion, and Tier 3 = <USD 1.0 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The players operating in the Pediatric Vascular Access market include BD (US), Teleflex Incorporated (US), ICU Medical, Inc. (US), B. Braun SE (Germany), Angiodynamics, Inc. (US), Terumo Corporation (Japan), Nipro Medical Corporation (Japan), and Medtronic Plc (Ireland)

Research Coverage

This report studies the pediatric vascular access market based on type, applications, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.

This report provides insights into the following pointers:

• Analysis of key drivers (increasing prevalence of preterm births, advancements in catheter materials in terms of safety and comfort, and growing NICU admissions), restraints (high prices of vascular access devices), opportunities (technological advancements), challenges (balancing innovations with cost-effectiveness)
• Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the pediatric vascular access market
• Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the Pediatric Vascular Access market
• Market Development: Complete knowledge about profitable developing regions
• Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the pediatric vascular access industry helps to diversify the market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as BD, Teleflex Incorporated, ICU Medical, Inc., B. Braun SE, AngioDynamics, Inc., Terumo Corporation, Nipro Medical Corporation, and Medtronic Plc.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 List of secondary sources
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 List of primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Breakdown of primary interviews
    • 2.1.2.4 Insights from industry experts
• 2.2 MARKET SIZE ESTIMATION
• 2.3 DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
  • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.5.2 SCOPE-RELATED LIMITATIONS
• 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PEDIATRIC VASCULAR ACCESS MARKET
• 4.2 PEDIATRIC VASCULAR ACCESS MARKET, BY REGION

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rapidly growing pediatric population
    • 5.2.1.2 Rise of pediatric cancer
    • 5.2.1.3 Heightened use of vascular access devices in pediatric patients
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Costly placement and maintenance of Pediatric vascular access devices
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Technological advancements in vascular access devices
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Shortage of skilled healthcare professionals
• 5.3 TECHNOLOGY ANALYSIS
  • 5.3.1 KEY TECHNOLOGIES
    • 5.3.1.1 Imaging and navigation
    • 5.3.1.2 Catheter securement and stabilization
  • 5.3.2 COMPLEMENTARY TECHNOLOGIES
    • 5.3.2.1 Artificial intelligence and machine learning
  • 5.3.3 ADJACENT TECHNOLOGIES
    • 5.3.3.1 Infection control technologies
• 5.4 INDUSTRY TRENDS
  • 5.4.1 MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES
  • 5.4.2 INNOVATIONS IN CATHETER MATERIALS AND COATINGS
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 SUPPLY CHAIN ANALYSIS
• 5.8 TRADE ANALYSIS
  • 5.8.1 IMPORT SCENARIO (HS CODE 901839)
  • 5.8.2 EXPORT SCENARIO (HS CODE 901839)
• 5.9 PORTER'S FIVE FORCES ANALYSIS
  • 5.9.1 THREAT OF NEW ENTRANTS
  • 5.9.2 THREAT OF SUBSTITUTES
  • 5.9.3 BARGAINING POWER OF BUYERS
  • 5.9.4 BARGAINING POWER OF SUPPLIERS
  • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.10.2 BUYING CRITERIA
• 5.11 REGULATORY LANDSCAPE
  • 5.11.1 REGULATORY FRAMEWORK
    • 5.11.1.1 North America
      • 5.11.1.1.1 US
      • 5.11.1.1.2 Canada
    • 5.11.1.2 Europe
    • 5.11.1.3 Asia Pacific
    • 5.11.1.4 Latin America
    • 5.11.1.5 Middle East & Africa
  • 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.12 PATENT ANALYSIS
• 5.13 PRICING ANALYSIS
  • 5.13.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.13.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.14 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.15 ADJACENT MARKET ANALYSIS
  • 5.15.1 VASCULAR ACCESS DEVICE MARKET
• 5.16 UNMET NEEDS/END USER EXPECTATIONS
• 5.17 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.18 INVESTMENT AND FUNDING SCENARIO
• 5.19 IMPACT OF AI/GEN AI
• 5.20 US 2025 TARIFF
  • 5.20.1 INTRODUCTION
  • 5.20.2 KEY TARIFF RATES
  • 5.20.3 PRICE IMPACT ANALYSIS
  • 5.20.4 IMPACT ON COUNTRY/REGION
    • 5.20.4.1 US
    • 5.20.4.2 Europe
    • 5.20.4.3 Asia Pacific
  • 5.20.5 IMPACT ON END-USE INDUSTRY

6 PEDIATRIC VASCULAR ACCESS MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 CATHETERS
  • 6.2.1 CENTRAL VENOUS CATHETERS
    • 6.2.1.1 Increased prevalence of preterm births to drive market
  • 6.2.2 PERIPHERAL INTRAVENOUS CATHETERS
    • 6.2.2.1 Rapid adoption of minimally invasive procedures to drive market
  • 6.2.3 PERIPHERALLY INSERTED CENTRAL CATHETERS
    • 6.2.3.1 Need for long-term vascular access in premature neonates to drive market
  • 6.2.4 MIDLINE CATHETERS
    • 6.2.4.1 Advancements in catheter materials and insertion techniques to drive market
• 6.3 CATHETER SECUREMENT & STABILIZATION
  • 6.3.1 IMPROVED AWARENESS ABOUT CATHETER STABILIZATION TO DRIVE MARKET
• 6.4 IMPLANTABLE PORTS
  • 6.4.1 RISING INCIDENCES OF PEDIATRIC CANCER TO DRIVE MARKET
• 6.5 PORT NEEDLES
  • 6.5.1 INCREASED USE OF IMPLANTABLE PORTS IN PEDIATRIC CARE TO DRIVE MARKET
• 6.6 INFUSION PUMPS
  • 6.6.1 HEIGHTENED DEMAND FOR PRECISE DRUG DELIVERY IN PEDIATRIC CARE TO DRIVE MARKET
• 6.7 IV CONNECTORS
  • 6.7.1 STRINGENT HOSPITAL PROTOCOLS TO DRIVE MARKET
• 6.8 SYRINGES & NEEDLES
  • 6.8.1 NEED FOR SAFE DRUG ADMINISTRATION IN PEDIATRICS TO DRIVE MARKET
• 6.9 VASCULAR CLOSURE DEVICES
  • 6.9.1 SURGE IN MINIMALLY INVASIVE PROCEDURES IN PEDIATRIC TO DRIVE MARKET
• 6.10 IV SETS & ACCESSORIES
  • 6.10.1 RISE IN PEDIATRIC CONDITIONS REQUIRING INTRAVENOUS THERAPY TO DRIVE MARKET
• 6.11 ANESTHESIA INJECTION DEVICES
  • 6.11.1 GROWING PEDIATRICS PROCEDURES TO DRIVE MARKET
• 6.12 GUIDANCE DEVICES
  • 6.12.1 ESCALATING DEMAND FOR SAFER AND MORE EFFECTIVE VASCULAR ACCESS PROCEDURES TO DRIVE MARKET
• 6.13 CATHETER CAPS & CLOSURES
  • 6.13.1 ADOPTION OF INFECTION PREVENTION PROTOCOLS BY PEDIATRIC CARE UNITS TO DRIVE MARKET
• 6.14 INTRAOSSEOUS INFUSION DEVICES
  • 6.14.1 RISING PEDIATRIC EMERGENCIES AND SEPSIS CASES TO DRIVE MARKET
• 6.15 OTHER TYPES

7 PEDIATRIC VASCULAR ACCESS MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 FLUID & NUTRITION ADMINISTRATION
  • 7.2.1 NEED FOR PRECISE, CONTINUOUS THERAPY IN PEDIATRIC POPULATION TO DRIVE MARKET
• 7.3 DRUG ADMINISTRATION
  • 7.3.1 RISE IN PEDIATRIC HEALTH COMPLEXITIES TO DRIVE MARKET
• 7.4 DIAGNOSTICS & TESTING
  • 7.4.1 ELEVATED DEMAND FOR EARLY DISEASE DETECTION, SEPSIS MANAGEMENT, AND MONITORING TO DRIVE MARKET
• 7.5 BLOOD TRANSFUSION
  • 7.5.1 PREVALENCE OF PRETERM BIRTHS AND NEONATAL ANEMIA TO DRIVE MARKET

8 PEDIATRIC VASCULAR ACCESS MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS
  • 8.2.1 GROWING NICU ADMISSIONS DUE TO PREMATURE BIRTHS AND CONGENITAL CONDITIONS TO DRIVE MARKET
• 8.3 AMBULATORY SURGICAL CENTERS & CLINICS
  • 8.3.1 INCREASING PREFERENCE FOR OUTPATIENT CARE TO DRIVE MARKET
• 8.4 HOMECARE SETTINGS
  • 8.4.1 EMERGING TREND OF EARLY HOSPITAL DISCHARGE TO DRIVE MARKET
• 8.5 OTHER END USERS

9 PEDIATRIC VASCULAR ACCESS MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK
  • 9.2.2 US
    • 9.2.2.1 Increasing burden of pediatric cancer to drive market
  • 9.2.3 CANADA
    • 9.2.3.1 Rising preterm births and NICU admissions to drive market
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK
  • 9.4.2 JAPAN
    • 9.4.2.1 Growing focus on pediatric care to drive market
  • 9.4.3 CHINA
    • 9.4.3.1 Substantial investments in healthcare infrastructure to drive market
  • 9.4.4 REST OF ASIA PACIFIC

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2024
• 10.3 REVENUE ANALYSIS, 2022-2024
• 10.4 MARKET SHARE ANALYSIS, 2024
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Region footprint
    • 10.5.5.3 Type footprint
    • 10.5.5.4 Application footprint
    • 10.5.5.5 End user footprint
• 10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING
    • 10.6.5.1 List of start-ups/SMEs
    • 10.6.5.2 Competitive benchmarking of start-ups/SMEs
• 10.7 COMPANY VALUATION AND FINANCIAL METRICS
• 10.8 BRAND/PRODUCT COMPARISON
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES & APPROVALS
  • 10.9.2 DEALS
  • 10.9.3 OTHER DEVELOPMENTS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 BECTON, DICKINSON AND COMPANY
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 MnM view
      • 11.1.1.3.1 Key strengths
      • 11.1.1.3.2 Strategic choices
      • 11.1.1.3.3 Weaknesses & competitive threats
  • 11.1.2 TELEFLEX INCORPORATED
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches & approvals
      • 11.1.2.3.2 Deals
      • 11.1.2.3.3 Other developments
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Key strengths
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 ICU MEDICAL, INC.
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 B. BRAUN SE
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product launches & approvals
      • 11.1.4.3.2 Deals
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 TERUMO CORPORATION
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 MnM view
      • 11.1.5.3.1 Right to win
      • 11.1.5.3.2 Strategic choice
      • 11.1.5.3.3 Weaknesses & competitive threats
  • 11.1.6 MEDTRONIC
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
  • 11.1.7 VYGON
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
  • 11.1.8 NIPRO CORPORATION
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
  • 11.1.9 ANGIODYNAMICS
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Product launches & approvals
      • 11.1.9.3.2 Deals
  • 11.1.10 COOK MEDICAL
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
• 11.2 OTHER PLAYERS
  • 11.2.1 CANADIAN HOSPITAL SPECIALTIES LIMITED
  • 11.2.2 MERIT MEDICAL SYSTEMS, INC.
  • 11.2.3 MEDICAL COMPONENTS, INC.
  • 11.2.4 AMECATH
  • 11.2.5 ARGON MEDICAL DEVICES
  • 11.2.6 HEALTH LINE INTERNATIONAL CORPORATION
  • 11.2.7 DELTA MED
  • 11.2.8 ACCESS VASCULAR, INC.
  • 11.2.9 PAKUMEDMEDICAL PRODUCTS GMBH
  • 11.2.10 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
  • 11.2.11 PFM MEDICAL
  • 11.2.12 POLY MEDICURE LTD
  • 11.2.13 NEWTECH MEDICAL DEVICES PVT. LTD.
  • 11.2.14 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.
  • 11.2.15 ANGIPLAST PRIVATE LIMITED

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS